{
    "2018-09-17": [
        [
            {
                "time": "2018-09-24",
                "original_text": "DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline - September 24, 2018",
                "features": {
                    "keywords": [
                        "Class Action",
                        "AbbVie",
                        "Investors",
                        "Deadline"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "AbbVie to Host Third-Quarter 2018 Earnings Conference Call",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Conference Call",
                        "AbbVie",
                        "Third-Quarter"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Why Gilead Stock Is a Sleepy Giant Waiting to Break Out",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Stock",
                        "Sleepy Giant",
                        "Break Out"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Zacks Analyst Blog Highlights: JPMorgan, Mastercard, AbbVie, CVS Health and Estee Lauder",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "JPMorgan",
                        "Mastercard",
                        "AbbVie",
                        "CVS Health",
                        "Estee Lauder"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}